A beneficial probiotic microbe called Limosilactobacillus_reuteri modulates the intestinal milieu by producing antimicrobial compounds, enhances insulin sensitivity and glucose balance, and alleviates metabolic disorders [40,41]. This evidence concerns the gene INS and Other metabolic disease.